Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Aminoisoquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ruthenium-catalyzed route offers high-purity pharmaceutical intermediates with simplified supply chain and cost reduction capabilities.
Patent CN113735770B details a novel Rh-catalyzed route to 1-aminoisoquinolines using vinylene carbonate, offering safer reagents and improved atom economy for industrial API manufacturing.
This patent details a copper-catalyzed synthesis for 1-naphthylamine derivatives offering high yields. It enables cost reduction and scalable manufacturing for reliable pharmaceutical intermediate suppliers globally.